Treatment with the inhaled gene therapy 4D-710 led to clinically meaningful quality of life gains for people with…
Articles by Marisa Wexler, MS
The first person with cystic fibrosis (CF) has been dosed with CM001, an experimental inhaled therapy being developed by…
Moligo Technologies is teaming up with Nationwide Children’s Hospital on a new project to develop a non-viral gene therapy…
A new study called ENHANCE is seeking to better understand the current effect of cystic fibrosis (CF) in young…
Researchers have developed new synthetic molecules that can transport chloride salts across cell membranes, which showed promise for restoring normal…
Men with cystic fibrosis (CF) commonly have low testosterone levels, though this is likely underrecognized due to a lack…
The lungs of people with cystic fibrosis (CF) harbor stem cells with a distinctive proinflammatory genetic signature, a new…
ReCode Therapeutics has raised $50 million in extended series B financing, which the company plans to use to help…
A type of bacteria called Achromobacter, which can cause problematic lung infections in people with cystic fibrosis (CF), uses…
CFTR — the protein whose defect or absence causes cystic fibrosis (CF) — helps cells called ionocytes remove liquid…